As shown in Figure 1B, expression of IL-32D and IL-32θ isoforms was significantly higher in HIV+ individuals with subclinical atherosclerosis (herein referred to as HIV+plaque+) compared to their HIV+plaqueneg counterparts (p=0.009 and p=0.004, respectively). Here, IL32 is linked to atherosclerosis.